The main objective is to assess the measurement characteristics (validity, reproducibility)
and the invariance of EGOMAC scale in a population of consultants in diabetology, cardiology
and rheumatology hospital and liberal and hospital oncology and Infectious disease, by
following the evolution of patient compliance at D0 and D15.
The second objective is to assess the sensitivity to change of scale EGOMAC following
developments compliance 3 months.